Potential of NOTCH1 Mutation to Predict Anti-PD1 Treatment Outcomes in Patients with Oesophageal Squamous Cell Cancer By Ogkologos - April 23, 2025 666 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a biomarker analysis from the RATIONALE-302 study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR More Than 25 Additional Years Needed to Slow an Increasing Incidence... September 8, 2021 Amivantamab Demonstrates Robust Efficacy in Patients with EGFR Exon 20 Insertion-Mutated... August 4, 2021 Tumour Signatures Defined by Next Generation Sequencing Are Linked to Clinical... March 2, 2021 Dr Ian Walker on Smoking: ‘A political no-brainer’ March 24, 2023 Load more HOT NEWS Breast Cancer Death Rates Will Rise in Elderly EU Patients but... Bean there done that: Can swapping to pulses be the new... Cancer in My Community: Obstacles to Caring for People With Cancer... Study Shows That Fast-Mimicking Diets Are Safe and Effective for Patients...
